Lynas Rare Earths Stock And 2 Australian Value Picks Trading Below Fair Value

Central banks are wrestling with inflation and interest rate questions, yet the PBoC is holding its loan prime rates at record lows. That means pockets of support still exist while many investors remain cautious. This disconnect can leave high quality undervalued stocks mispriced. In this article you will see three stocks from our High Quality Undervalued Stocks screener that combine strong fundamentals with attractive entry points.

The three stocks below are just a starting sample from this idea. The full screen surfaced 11 more companies with equally compelling narratives that are not covered here. To identify, analyze and shortlist your own highest conviction candidates, head straight into the High Quality Undervalued Stocks screener.

Cochlear (ASX:COH)

Overview: Cochlear is a Sydney based medical device company that provides implantable hearing solutions for children and adults, with its Nucleus and Osia cochlear implant systems and replacement processors driving recurring revenue through device upgrades, accessories, and lifelong support services. Alongside this core franchise that anchors its fit in the High Quality Undervalued Stocks theme, Cochlear also offers bone conduction products and connected care software under brands such as Cochlear, Nucleus, Nexa, Osia, and Baha.

Operations: Cochlear generates about A$2.3b in revenue primarily from its Implantable Hearing Device segment, with significant contributions from the Americas at A$1.2b and EMEA at A$803 million, and additional sales across Asia Pacific.

Market Cap: A$8.9b

Cochlear may appeal if you are looking for a high quality healthcare stock where the main story is an entrenched implant ecosystem that earns recurring cash flows from Nucleus and Osia devices, upgrades, and services. The stock currently trades below one estimate of fair value based on that same analysis. The company is working through margin pressure, a recent A$215.7 million one off loss, and a lower 6.3% net margin. Analysts currently have a consensus price target of A$124.4 compared with a share price of around A$111 today. That mix of franchise strength, a growing installed base, and balance sheet and margin issues that management is addressing is what may make Cochlear worth a closer look in this screener.

Cochlear’s entrenched implant ecosystem and recurring cash flows often grab attention, yet the real story may sit in how its balance sheet and margins line up against that franchise strength. To see how those pieces fit together, go through the Cochlear financial health report

Build your own high quality Cochlear style shortlist

Cochlear and the other two stocks in this article all came from a single screener, but the real value comes when you shape the filters yourself. Use our flexible Screener to blend valuation, quality, growth, balance sheet and risk metrics into your own watchlist, or tap into our curated Investing Ideas for ready made starting points.

Superloop (ASX:SLC)

Overview: Superloop is an Australian telecommunications company that supplies fibre based broadband, NBN enterprise ethernet, dark fibre and international subsea capacity to wholesale, business and consumer customers, with its wholesale and enterprise links providing the clearest connection to the High Quality Undervalued Stocks theme through recurring cash flows from large scale clients. Alongside these core network services, Superloop also offers residential internet and mobile, Wi-Fi and voice solutions, and a growing suite of cyber security and smart community connectivity products.

Operations: Superloop generates about A$413 million of revenue from its Consumer segment, A$107 million from Business customers and A$87 million from Wholesale services.

Market Cap: A$1.6b

Superloop may appeal to investors who are looking for a telecom stock where high quality, recurring wholesale and enterprise cash flows line up with a valuation that screens as undervalued. The company is leaning into demand for high speed fibre and smart communities, reporting A$666.68 million of revenue and A$17.53 million of net income for FY2026, along with a 50% uplift in free cash flow and progress on its three year “Double Down” plan. However, growth expectations are already high, competition in consumer and enterprise access is intense, and the business relies on external debt funding and ongoing acquisitions. If Superloop continues to convert growth into cash while managing these risks, the investment case highlighted by this screener could become more compelling.

Superloop’s growth story and heavy investment in fibre, smart communities and acquisitions often look exciting on the surface. The real question is how the moving parts fit together in one coherent thesis, which is exactly what the analysis report for Superloop

Lynas Rare Earths (ASX:LYC)

Overview: Lynas Rare Earths is an Australian company that mines and processes rare earth minerals from its Mt Weld operation and downstream plants in Kalgoorlie and Malaysia, supplying key materials like neodymium and praseodymium that are used in permanent magnets for electric motors and wind turbines. This focus on rare earth oxides for clean energy and electrification supply chains is the clearest link to the High Quality Undervalued Stocks theme.

Operations: Lynas Rare Earths generates around A$715.89 million of revenue from its Rare Earth Operations segment.

Market Cap: A$16.3b

Investors looking at high quality undervalued ideas may find Lynas Rare Earths worth attention because it sits at the intersection of critical materials for electrification and a share price that some assessments suggest is trading well below estimated fair value. The company already earns money from its integrated rare earths chain and is tied directly into demand for permanent magnets in EVs and wind turbines. However, its narrow product focus, capital intensive plants and reliance on external borrowing mean execution and funding risks are real. With key earnings updates scheduled through 2026 and policy support for non Chinese rare earth supply in focus, the gap between Lynas’s clean energy exposure and the risks around pricing, regulation and expansion is where the opportunity or disappointment will likely emerge.

Lynas Rare Earths is tied to clean energy growth, yet the full story often feels incomplete. Scan the analysis report for Lynas Rare Earths to see how rare earth pricing, policy support and project timing could suddenly realign.

Seeking Alternatives Before The Crowd?

Fresh opportunities can move from quiet to flying quickly. Use these under-the-radar-for-now stock lists while the window feels open and prices still matter. Consider acting early if it fits your strategy.

• Track where early momentum may be building by scanning a curated set of under-followed companies through the 11 high quality undiscovered gems.
• Target resilient cash generators and stress test your income ideas against a curated pool of 6 dividend fortresses before yields move.
• Position ahead of potential infrastructure themes by reviewing pre-filtered 39 power grid technology and infrastructure stocks that could benefit if grid upgrades gain momentum.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com